{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:49:33Z","timestamp":1790794173548,"version":"4.1.0"},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The purpose of this review is to provide a synthesis of recent discoveries about type-2 innate lymphoid cells, especially, as they relate to the pathogenesis of asthma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>We focused on features and characteristics of type-2 innate lymphoid cells (ILC2s) that distinguish them from other type-2 cells, especially Th2 cells. We collected and reviewed data related to human asthma and airway ILC2s. We examined the concept of ILC2 memory and trained immunity. We also analyzed steroid resistance of ILC2s, which is relevant for steroid-resistant asthma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>The implications of the findings include an understanding of ILC2 inflammation, and pathways and molecules that can be targeted by biologics and other therapeutic agents for management severe and steroid-resistant asthma<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aci.0000000000000798","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T02:00:10Z","timestamp":1638151210000},"page":"29-35","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Role of type-2 innate lymphoid cells (ILC2s) in type-2 asthma"],"prefix":"10.1097","volume":"22","author":[{"given":"Mukesh","family":"Verma","sequence":"first","affiliation":[{"name":"Division of Allergy & Immunology, Department of Medicine, National Jewish Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Verma","sequence":"additional","affiliation":[{"name":"Division of Allergy & Immunology, Department of Medicine, National Jewish Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafeul","family":"Alam","sequence":"additional","affiliation":[{"name":"Division of Allergy & Immunology, Department of Medicine, National Jewish Health"},{"name":"University of Colorado Denver, School of Medicine, Denver, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,11,24]]},"reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"100080","DOI":"10.1016\/j.waojou.2019.100080","article-title":"IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper","volume":"13","author":"Ansotegui","year":"2020","journal-title":"World Allergy Organ J"},{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/all.14318","article-title":"Type 2 immunity in the skin and lungs","volume":"75","author":"Akdis","year":"2020","journal-title":"Allergy"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40413-018-0192-5","article-title":"Type 2 immunity in asthma","volume":"11","author":"Caminati","year":"2018","journal-title":"World Allergy Organ J"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1164\/rccm.201611-2232PP","article-title":"Eosinophilic and noneosinophilic asthma","volume":"197","author":"Carr","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12016-018-8712-1","article-title":"Understanding asthma phenotypes, endotypes, and mechanisms of disease","volume":"56","author":"Kuruvilla","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/all.13985","article-title":"Mechanisms and therapeutic strategies for non-T2 asthma","volume":"75","author":"Sze","year":"2020","journal-title":"Allergy"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jaci.2018.06.008","article-title":"Paucigranulocytic asthma: uncoupling of airway obstruction from inflammation","volume":"143","author":"Tliba","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.immuni.2019.03.018","article-title":"The cytokines of asthma","volume":"50","author":"Lambrecht","year":"2019","journal-title":"Immunity"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0140-6736(19)33005-3","article-title":"Intersection of biology and therapeutics: type 2 targeted therapeutics for adult asthma","volume":"395","author":"Peters","year":"2020","journal-title":"Lancet"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.immuni.2014.01.011","article-title":"Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation","volume":"40","author":"Halim","year":"2014","journal-title":"Immunity"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/nri2870","article-title":"Functions of T cells in asthma: more than just T(H)2 cells","volume":"10","author":"Lloyd","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jaci.2009.02.013","article-title":"Natural killer T cells in the lungs of patients with asthma","volume":"123","author":"Matangkasombut","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3389\/fimmu.2019.00861","article-title":"Innate lymphoid cells in mucosal immunity","volume":"10","author":"Panda","year":"2019","journal-title":"Front Immunol"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jaci.2009.07.022","article-title":"Natural killer T cells in bronchial biopsies from human allergen challenge model of allergic asthma","volume":"124","author":"Reynolds","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1056\/NEJM199201303260504","article-title":"Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma","volume":"326","author":"Robinson","year":"1992","journal-title":"N Engl J Med"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.4049\/jimmunol.158.7.3539","article-title":"Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics","volume":"158","author":"Ying","year":"1997","journal-title":"J Immunol"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.4049\/jimmunol.179.5.2787","article-title":"CD8+ T cell-mediated airway hyperresponsiveness and inflammation is dependent on CD4+IL-4+ T cells","volume":"179","author":"Koya","year":"2007","journal-title":"J Immunol"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa1411776","article-title":"Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme","volume":"372","author":"Krug","year":"2015","journal-title":"N Engl J Med"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/09031936.01.00064101","article-title":"The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma","volume":"18","author":"Kon","year":"2001","journal-title":"Eur Respir J"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1164\/rccm.200708-1200OC","article-title":"Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial","volume":"178","author":"Busse","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature14189","article-title":"The biology of innate lymphoid cells","volume":"517","author":"Artis","year":"2015","journal-title":"Nature"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"aaa6566","DOI":"10.1126\/science.aaa6566","article-title":"Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology","volume":"348","author":"Eberl","year":"2015","journal-title":"Science"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells\u2014a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"R24-20250527","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/ni.3482","article-title":"NK cells and type 1 innate lymphoid cells: partners in host defense","volume":"17","author":"Spits","year":"2016","journal-title":"Nat Immunol"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"key":"R26-20250527","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ni.2131","article-title":"Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus","volume":"12","author":"Monticelli","year":"2011","journal-title":"Nat Immunol"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jaci.2020.01.038","article-title":"Optimal identification of human conventional and nonconventional (CRTH2(\u2212)IL7Ralpha(\u2212)) ILC2s using additional surface markers","volume":"146","author":"Liu","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"R28-20250527","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.jaci.2019.07.018","article-title":"Unconventional ST2- and CD127-negative lung ILC2 populations are induced by the fungal allergen Alternaria alternata","volume":"144","author":"Cavagnero","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"R29-20250527","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature08636","article-title":"Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells","volume":"463","author":"Moro","year":"2010","journal-title":"Nature"},{"key":"R30-20250527","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-2600(16)30179-5","article-title":"Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial","volume":"4","author":"Gonem","year":"2016","journal-title":"Lancet Respir Med"},{"key":"R31-20250527","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41467-017-00678-2","article-title":"Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis","volume":"8","author":"Trabanelli","year":"2017","journal-title":"Nat Commun"},{"key":"R32-20250527","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/JLB.5MA0120-209R","article-title":"Distinct and shared gene expression for human innate versus adaptive helper lymphoid cells","volume":"108","author":"Ercolano","year":"2020","journal-title":"J Leukoc Biol"},{"key":"R33-20250527","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41586-021-03188-w","article-title":"Skin-resident innate lymphoid cells converge on a pathogenic effector state","volume":"592","author":"Bielecki","year":"2021","journal-title":"Nature"},{"key":"R34-20250527","doi-asserted-by":"crossref","first-page":"174ra26","DOI":"10.1126\/scitranslmed.3004812","article-title":"Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma","volume":"5","author":"Barnig","year":"2013","journal-title":"Sci Transl Med"},{"key":"R35-20250527","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jaci.2014.06.024","article-title":"Enhanced innate type 2 immune response in peripheral blood from patients with asthma","volume":"134","author":"Bartemes","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"R36-20250527","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/all.13997","article-title":"Eosinophil extracellular traps activate type 2 innate lymphoid cells through stimulating airway epithelium in severe asthma","volume":"75","author":"Choi","year":"2020","journal-title":"Allergy"},{"key":"R37-20250527","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaci.2017.03.032","article-title":"Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: The role of thymic stromal lymphopoietin","volume":"141","author":"Liu","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"R38-20250527","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.rmed.2015.09.016","article-title":"Type 2 innate lymphoid cells: a novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma","volume":"109","author":"Liu","year":"2015","journal-title":"Respir Med"},{"key":"R39-20250527","doi-asserted-by":"crossref","first-page":"e20201354","DOI":"10.1084\/jem.20201354","article-title":"The molecular and epigenetic mechanisms of innate lymphoid cell (ILC) memory and its relevance for asthma","volume":"218","author":"Verma","year":"2021","journal-title":"J Exp Med"},{"key":"R40-20250527","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000488050","article-title":"Increased Group 2 innate lymphoid cells are correlated with eosinophilic granulocytes in patients with allergic airway inflammation","volume":"176","author":"Yu","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"key":"R41-20250527","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1164\/rccm.201406-1039OC","article-title":"IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo","volume":"190","author":"Jackson","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"R42-20250527","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1111\/all.13438","article-title":"ILC2 frequency and activity are inhibited by glucocorticoid treatment via STAT pathway in patients with asthma","volume":"73","author":"Yu","year":"2018","journal-title":"Allergy"},{"key":"R43-20250527","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1164\/rccm.201612-2427OC","article-title":"Allergen-induced Increases in Sputum Levels of Group 2 innate lymphoid cells in subjects with asthma","volume":"196","author":"Chen","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R44-20250527","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1164\/rccm.201909-1722OC","article-title":"The role of the TL1A\/DR3 axis in the activation of Group 2 innate lymphoid cells in subjects with eosinophilic asthma","volume":"202","author":"Machida","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"R45-20250527","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaci.2015.05.037","article-title":"Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia","volume":"137","author":"Smith","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"R46-20250527","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaci.2014.11.037","article-title":"Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33","volume":"136","author":"Christianson","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"R47-20250527","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaci.2019.01.027","article-title":"Activation of group 2 innate lymphoid cells after allergen challenge in asthmatic patients","volume":"144","author":"Winkler","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"R48-20250527","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202010-3754OC","article-title":"Pulmonary innate lymphoid cell responses during rhinovirus-induced asthma exacerbations in vivo: a clinical trial","author":"Dhariwal","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"R49-20250527","doi-asserted-by":"crossref","first-page":"e0171047","DOI":"10.1371\/journal.pone.0171047","article-title":"Impact of chronic rhinosinusitis on severe asthma patients","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"key":"R50-20250527","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/imr.12706","article-title":"The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms","volume":"286","author":"Kabata","year":"2018","journal-title":"Immunol Rev"},{"key":"R51-20250527","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ni.3489","article-title":"Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis","volume":"17","author":"Klose","year":"2016","journal-title":"Nat Immunol"},{"key":"R52-20250527","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/mi.2013.114","article-title":"The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells","volume":"7","author":"Meylan","year":"2014","journal-title":"Mucosal Immunol"},{"key":"R53-20250527","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/mi.2013.92","article-title":"TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers","volume":"7","author":"Yu","year":"2014","journal-title":"Mucosal Immunol"},{"key":"R54-20250527","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat9453","article-title":"The cysteinyl leukotriene 3 receptor regulates expansion of IL-25-producing airway brush cells leading to type 2 inflammation","volume":"3","author":"Bankova","year":"2018","journal-title":"Sci Immunol"},{"key":"R55-20250527","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature16161","article-title":"Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit","volume":"529","author":"von Moltke","year":"2016","journal-title":"Nature"},{"key":"R56-20250527","doi-asserted-by":"crossref","first-page":"A4269","DOI":"10.1164\/ajrccm-conference.2020.201.1_MeetingAbstracts.A4269","article-title":"SAR440340, an anti-IL-33 monoclonal antibody, demonstrated a significant reduction of LOAC events and improved Pre-BD FEV1 in patients with moderate to severe asthma: results from the phase 2 proof of concept study, in B101","author":"Wechsler","year":"2020","journal-title":"New Biol Treat Asthma"},{"key":"R57-20250527","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaci.2021.03.044","article-title":"Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: a randomized clinical trial","volume":"148","author":"Kelsen","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"R58-20250527","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nature23676","article-title":"The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation","volume":"549","author":"Klose","year":"2017","journal-title":"Nature"},{"key":"R59-20250527","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature24029","article-title":"The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation","volume":"549","author":"Wallrapp","year":"2017","journal-title":"Nature"},{"key":"R60-20250527","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.immuni.2019.09.005","article-title":"Calcitonin gene-related peptide negatively regulates alarmin-driven type 2 innate lymphoid cell responses","volume":"51","author":"Wallrapp","year":"2019","journal-title":"Immunity"},{"key":"R61-20250527","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1172\/JCI124609","article-title":"Neuro-immune crosstalk and allergic inflammation","volume":"129","author":"Kabata","year":"2019","journal-title":"J Clin Investig"},{"key":"R62-20250527","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neuron.2015.06.007","article-title":"Silencing nociceptor neurons reduces allergic airway inflammation","volume":"87","author":"Talbot","year":"2015","journal-title":"Neuron"},{"key":"R63-20250527","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41590-020-0753-y","article-title":"Basophils prime group 2 innate lymphoid cells for neuropeptide-mediated inhibition","volume":"21","author":"Inclan-Rico","year":"2020","journal-title":"Nat Immunol"},{"key":"R64-20250527","doi-asserted-by":"crossref","first-page":"eaan8546","DOI":"10.1126\/science.aan8546","article-title":"Pulmonary neuroendocrine cells amplify allergic asthma responses","volume":"360","author":"Sui","year":"2018","journal-title":"Science"},{"key":"R65-20250527","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1126\/science.aan4829","article-title":"beta2-adrenergic receptor-mediated negative regulation of group 2 innate lymphoid cell responses","volume":"359","author":"Moriyama","year":"2018","journal-title":"Science"},{"key":"R66-20250527","doi-asserted-by":"crossref","first-page":"eabe3218","DOI":"10.1126\/sciimmunol.abe3218","article-title":"The ChAT-acetylcholine pathway promotes group 2 innate lymphoid cell responses and antihelminth immunity","volume":"6","author":"Chu","year":"2021","journal-title":"Sci Immunol"},{"key":"R67-20250527","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.4049\/jimmunol.2000647","article-title":"MicroRNA-142 critically regulates Group 2 innate lymphoid cell homeostasis and function","volume":"206","author":"Roberts","year":"2021","journal-title":"J Immunol"},{"key":"R68-20250527","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.immuni.2016.06.017","article-title":"Allergen-experienced group 2 innate lymphoid cells acquire memory-like properties and enhance allergic lung inflammation","volume":"45","author":"Martinez-Gonzalez","year":"2016","journal-title":"Immunity"},{"key":"R69-20250527","doi-asserted-by":"crossref","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"key":"R70-20250527","doi-asserted-by":"crossref","first-page":"641404","DOI":"10.3389\/fcell.2021.641404","article-title":"Wnt signaling is deranged in asthmatic bronchial epithelium and fibroblasts","volume":"9","author":"Hachim","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R71-20250527","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1164\/rccm.201811-2221OC","article-title":"BAL cell gene expression in severe asthma reveals mechanisms of severe disease and influences of medications","volume":"200","author":"Weathington","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"R72-20250527","doi-asserted-by":"crossref","first-page":"eabd3489","DOI":"10.1126\/sciimmunol.abd3489","article-title":"Steroid-resistant human inflammatory ILC2s are marked by CD45RO and elevated in type 2 respiratory diseases","volume":"6","author":"van der Ploeg","year":"2021","journal-title":"Sci Immunol"},{"key":"R73-20250527","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.immuni.2014.06.016","article-title":"MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion","volume":"41","author":"Oliphant","year":"2014","journal-title":"Immunity"}],"container-title":["Current Opinion in Allergy &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACI.0000000000000798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T18:02:59Z","timestamp":1748368979000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ACI.0000000000000798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,24]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0000000000000798","relation":{},"ISSN":["1528-4050","1473-6322"],"issn-type":[{"value":"1528-4050","type":"print"},{"value":"1473-6322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,24]]}}}